Scope Ophthalmics Limited
Registered name: SCOPE OPHTHALMICS LIMITED
Scope Ophthalmics Limited made £46.6m revenue and £721k profit in the year to 31 Dec 2023.
Scope Ophthalmics Limited’s revenue grew 10% to £46.6m in the year to 31 Dec 2023, with £721k profit and 74 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Crawley; we hold 2 years of its filed accounts.
- Status
- Active
- Location
- Crawley, South East
- Age
- 14 yrs · since 2011
- Type
- Private Limited Company
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2022 | 31 Dec 2023 |
|---|---|---|
| Disclosure | Full P&L | Full P&L |
| Profit & loss | ||
| Revenue (turnover) | £42.4m | £46.6m |
| Cost of sales | £29.4m | £32.8m |
| Gross profit | £13m | £13.8m |
| Operating profit | £1.7m | £902k |
| Profit before tax | £1.7m | £959k |
| Profit after tax | £1.3m | £721k |
| Profit (best available) | £1.3m | £721k |
| Staff costs | £5.3m | £6.2m |
| Employees (average) | 74 | 74 |
| Ratios | ||
| Profit margin | 3.1% | 1.6% |
| Gross margin | 30.7% | 29.6% |
| Revenue per employee | £574k | £629k |
| Profit per employee | £18.1k | £9.7k |
| Cash conversion | −100.6% | −591.5% |
| Growth (year on year) | ||
| Revenue growth | — | ▲9.7% |
| Profit growth | — | ▼46.1% |
| Headcount growth | — | 0% |
| Balance sheet — indirect signals, not revenue | ||
| Cash at bank | −£2.8m | £6.9m |
| Net assets | — | — |
| Current assets | £29.1m | £33.2m |
| Debtors | £9.2m | £7.4m |
| Cash from operations | −£1.7m | −£5.3m |
| Source | Reports and Financial Statements · bulk data Oct 2024 | Reports and Financial Statements · bulk data Oct 2024 |
How the business works
- Profit margin
- 1.6%
- Profit ÷ revenue.
- Gross margin
- 29.6%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £629k
- Revenue ÷ average employees.
- Profit per employee
- £9.7k
- Profit ÷ average employees.
- Cash conversion
- −591.5%
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 16%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now —
- Cash at bank
- —
- Now £6.9m
- Headcount
- 0%
- Now 74
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Similar profitable businesses
- Waymade PLCBasildon · Wholesale of pharmaceutical goods
- Revenue
- £47.8m
- Profit
- £2.7m
- Staff
- 117
- Techdow Pharma England LimitedGuildford · Wholesale of pharmaceutical goods
- Revenue
- £48.8m
- Profit
- £871k
- Staff
- 12
- Inceptua LimitedWindsor · Wholesale of pharmaceutical goods
- Revenue
- £44.5m
- Profit
- £1.3m
- Staff
- 29
- Respond Healthcare LimitedNewtownards · Wholesale of pharmaceutical goods
- Revenue
- £50.4m
- Profit
- £1.2m
- Staff
- 114
- Genesis Pharmaceuticals LimitedHarrow · Wholesale of pharmaceutical goods
- Revenue
- £42.6m
- Profit
- £214k
- Staff
- 12
- Karo Healthcare UK LtdMaidenhead · Wholesale of pharmaceutical goods
- Revenue
- £54.4m
- Profit
- £1.8m
- Staff
- 78
Sources
Latest figures from Reports and Financial Statements for the year to 31 Dec 2023 (profit £721k), from the Companies House accounts bulk data published Oct 2024. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.